IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

Winter Springs, Florida, August 27, 2019 – IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer, will participate in the Morgan Stanley 17th Annual Global Healthcare Conference in New York from September 9, 2019 to September 11, 2019.

Read More
Kevin Jirka
Leslie McDonnell named as President and Chief Executive Officer

Winter Springs, Florida, July 29, 2019 – iRadimed Corporation (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step down as President and CEO on August 19, 2019 after leading the Company since its founding 27 years ago.

Read More
Kevin Jirka
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results

Winter Springs, Florida, April 16, 2019 – IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Read More
Kevin Jirka
IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue

Winter Springs, Florida, January 22, 2019 – IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices today announced that it temporarily suspended sales of its 3880 MRI compatible patient vital signs monitoring systems in European Commission (“EC”) markets due to the expiration of its CE Mark on January 17, 2019.

Read More
Kevin Jirka
First Quarter 2018 Financial Results Announced

For the first quarter ended March 31, 2018, the Company reported revenue of $7.1 million compared to $5.2 million for the first quarter 2017. Net income was $0.8 million, or $0.07 per diluted share, compared to a net loss of $(0.2) million, or $(0.02) per share for the first quarter 2017.

Read More
Kevin Jirka
2017 Fourth Quarter Financial Results Conference Call

 IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, February 6th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. 

Read More
Kevin Jirka